Roivant Sciences ROIV
NASDAQ ROIV
$36.50 -0.48 (-1.30%)
At close: Sep 29, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Operating Expenses (2020 - 2026)

Updated

Roivant Sciences (ROIV) recorded Operating Expenses of $367.83 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 28.1% from $287.09 million a year earlier and up 2.9% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Operating Expenses (2020 - 2026) Analysis & Trends

On a TTM basis, Roivant Sciences' Operating Expenses came in at $1.37 billion as of Jun 30, 2026, up 13.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $1.29 billion, up 13.2% from FY2025.

  • Annual Operating Expenses has a five-year compound annual growth rate of 3.4% (FY2021 to FY2026).
  • Across earlier fiscal years, Operating Expenses came in at $1.14 billion in FY2025 (+29.3%), $884.09 million in FY2024 (-5.8%), $938.29 million in FY2023 (-33.3%) and $1.41 billion in FY2022 (+28.5%).
  • The fiscal Q1 2027 figure is the highest quarterly Operating Expenses since fiscal Q3 2023.
  • On a year-over-year basis, Operating Expenses has increased for three consecutive quarters, with growth averaging 25.5% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 342.4% in fiscal Q2 2022, against a decline of 58.0% in fiscal Q2 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $357.52 million (Q4 2026), $341.15 million (Q3 2026) and $307.8 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Roivant Sciences 26.72 Bn 27.41 Bn 1.16 Mn 367.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 367.83 Mn
Mar 31, 2026 357.52 Mn
Dec 31, 2025 341.15 Mn
Sep 30, 2025 307.80 Mn
Jun 30, 2025 287.09 Mn
Mar 31, 2025 292.54 Mn
Dec 31, 2024 283.40 Mn
Sep 30, 2024 346.19 Mn
Jun 30, 2024 220.61 Mn
Mar 31, 2024 215.85 Mn
Dec 31, 2023 236.52 Mn
Sep 30, 2023 217.54 Mn
Jun 30, 2023 298.04 Mn
Mar 31, 2023 -36.76 Mn
Dec 31, 2022 395.13 Mn
Sep 30, 2022 293.30 Mn
Jun 30, 2022 286.63 Mn
Mar 31, 2022 276.03 Mn
Dec 31, 2021 270.36 Mn
Sep 30, 2021 698.42 Mn
API Access

Roivant Sciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ROIV&period=max&api_key=YOUR_API_KEY